Temasek injects $250m in a Chinese healthcare facility

It will form a 50-50 JV with Columbia Pacific.

Singapore's state-owned investment firm is looking forward to expand its healthcare holdings as it invests $250m in the China operations of Columbia Pacific Management.

The two firms will forge a 50-50 joint venture aimed at providing China's growing middle-class population with affordable health and elderly care services.

Columbia Pacific is known for its 40 years of experience in aged and health care. It oversees a network of modern hospitals and senior facilities in several locations in Asia.

The deal bolsters up Temasek's venture in health sector. It has already seen its life sciences and agriculture-related assets double to 4% in the past two years.

To recall, Temasek loaded up on stakes in US pharmaceutical and healthcare firms including Alexion Pharmaceuticals Inc. and Regeneron Pharmaceuticals Inc., which develop treatments for serious medical conditions.

Read more here.